Cargando…

Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway

BACKGROUND: Propofol is commonly used for anesthesia during surgery and has been demonstrated to inhibit cancer development, which is shown to be associated with deregulation of non-coding RNAs (ncRNAs). The objective of this study was to explore the role of circular RNA mucin 16 (circ_MUC16) in Pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hao, Guo, Yunrui, Zhang, Yecai, Wang, Decai, Zhang, Guoyun, Hou, Jiali, Yang, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626908/
https://www.ncbi.nlm.nih.gov/pubmed/34837947
http://dx.doi.org/10.1186/s12871-021-01517-0
_version_ 1784606748913434624
author Yang, Hao
Guo, Yunrui
Zhang, Yecai
Wang, Decai
Zhang, Guoyun
Hou, Jiali
Yang, Jianming
author_facet Yang, Hao
Guo, Yunrui
Zhang, Yecai
Wang, Decai
Zhang, Guoyun
Hou, Jiali
Yang, Jianming
author_sort Yang, Hao
collection PubMed
description BACKGROUND: Propofol is commonly used for anesthesia during surgery and has been demonstrated to inhibit cancer development, which is shown to be associated with deregulation of non-coding RNAs (ncRNAs). The objective of this study was to explore the role of circular RNA mucin 16 (circ_MUC16) in Propofol-mediated inhibition of ovarian cancer. METHODS: The expression of circ_MUC16, microRNA-1182 (miR-1182) and S100 calcium-binding protein B (S100B) mRNA was measured by quantitative real-time polymerase chain reaction (qPCR). The expression of S100B protein was checked by western blot. Cell proliferation was assessed by 3-(4, 5-di methyl thiazol-2-yl)-2, 5-di phenyl tetrazolium bromide (MTT) assay and colony formation assay. Glycolysis metabolism was assessed by glucose consumption, lactate production and ATP level. Cell migration and cell invasion were assessed by transwell assay. Cell migration was also assessed by wound healing assay. Animal study was conducted in nude mice to determine the role of circ_MUC16 in vivo. The relationship between miR-1182 and circ_MUC16 or S100B was validated by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. RESULTS: Propofol inhibited ovarian cancer cell proliferation, glycolysis metabolism, migration and invasion, which were partly recovered by circ_MUC16 overexpression. Circ_MUC16 was downregulated in Propofol-treated ovarian cancer cells. Besides, circ_MUC16 knockdown enhanced the effects of Propofol to further inhibit tumor growth in vivo. MiR-1182 was a target of circ_MUC16, and circ_MUC16 knockdown-inhibited cell proliferation, glycolysis metabolism, migration and invasion were partly restored by miR-1182 inhibition. In addition, S100B was a target of miR-1182, and miR-1182-suppressed cell proliferation, glycolysis metabolism, migration and invasion were partly restored by S100B overexpression. CONCLUSION: Circ_MUC16 overexpression alleviated the effects of Propofol to promote the aggressive behaviors of ovarian cancer by targeting the miR-1182/S100B network. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-021-01517-0.
format Online
Article
Text
id pubmed-8626908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86269082021-11-29 Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway Yang, Hao Guo, Yunrui Zhang, Yecai Wang, Decai Zhang, Guoyun Hou, Jiali Yang, Jianming BMC Anesthesiol Research Article BACKGROUND: Propofol is commonly used for anesthesia during surgery and has been demonstrated to inhibit cancer development, which is shown to be associated with deregulation of non-coding RNAs (ncRNAs). The objective of this study was to explore the role of circular RNA mucin 16 (circ_MUC16) in Propofol-mediated inhibition of ovarian cancer. METHODS: The expression of circ_MUC16, microRNA-1182 (miR-1182) and S100 calcium-binding protein B (S100B) mRNA was measured by quantitative real-time polymerase chain reaction (qPCR). The expression of S100B protein was checked by western blot. Cell proliferation was assessed by 3-(4, 5-di methyl thiazol-2-yl)-2, 5-di phenyl tetrazolium bromide (MTT) assay and colony formation assay. Glycolysis metabolism was assessed by glucose consumption, lactate production and ATP level. Cell migration and cell invasion were assessed by transwell assay. Cell migration was also assessed by wound healing assay. Animal study was conducted in nude mice to determine the role of circ_MUC16 in vivo. The relationship between miR-1182 and circ_MUC16 or S100B was validated by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. RESULTS: Propofol inhibited ovarian cancer cell proliferation, glycolysis metabolism, migration and invasion, which were partly recovered by circ_MUC16 overexpression. Circ_MUC16 was downregulated in Propofol-treated ovarian cancer cells. Besides, circ_MUC16 knockdown enhanced the effects of Propofol to further inhibit tumor growth in vivo. MiR-1182 was a target of circ_MUC16, and circ_MUC16 knockdown-inhibited cell proliferation, glycolysis metabolism, migration and invasion were partly restored by miR-1182 inhibition. In addition, S100B was a target of miR-1182, and miR-1182-suppressed cell proliferation, glycolysis metabolism, migration and invasion were partly restored by S100B overexpression. CONCLUSION: Circ_MUC16 overexpression alleviated the effects of Propofol to promote the aggressive behaviors of ovarian cancer by targeting the miR-1182/S100B network. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-021-01517-0. BioMed Central 2021-11-27 /pmc/articles/PMC8626908/ /pubmed/34837947 http://dx.doi.org/10.1186/s12871-021-01517-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yang, Hao
Guo, Yunrui
Zhang, Yecai
Wang, Decai
Zhang, Guoyun
Hou, Jiali
Yang, Jianming
Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway
title Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway
title_full Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway
title_fullStr Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway
title_full_unstemmed Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway
title_short Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway
title_sort circ_muc16 attenuates the effects of propofol to promote the aggressive behaviors of ovarian cancer by mediating the mir-1182/s100b signaling pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626908/
https://www.ncbi.nlm.nih.gov/pubmed/34837947
http://dx.doi.org/10.1186/s12871-021-01517-0
work_keys_str_mv AT yanghao circmuc16attenuatestheeffectsofpropofoltopromotetheaggressivebehaviorsofovariancancerbymediatingthemir1182s100bsignalingpathway
AT guoyunrui circmuc16attenuatestheeffectsofpropofoltopromotetheaggressivebehaviorsofovariancancerbymediatingthemir1182s100bsignalingpathway
AT zhangyecai circmuc16attenuatestheeffectsofpropofoltopromotetheaggressivebehaviorsofovariancancerbymediatingthemir1182s100bsignalingpathway
AT wangdecai circmuc16attenuatestheeffectsofpropofoltopromotetheaggressivebehaviorsofovariancancerbymediatingthemir1182s100bsignalingpathway
AT zhangguoyun circmuc16attenuatestheeffectsofpropofoltopromotetheaggressivebehaviorsofovariancancerbymediatingthemir1182s100bsignalingpathway
AT houjiali circmuc16attenuatestheeffectsofpropofoltopromotetheaggressivebehaviorsofovariancancerbymediatingthemir1182s100bsignalingpathway
AT yangjianming circmuc16attenuatestheeffectsofpropofoltopromotetheaggressivebehaviorsofovariancancerbymediatingthemir1182s100bsignalingpathway